In this Issue
Are improved diagnostics and new drugs the answer to maximizing outcomes in DR and DME?
By Robert L. Avery, MD, Associate Medical Editor and Allen C. Ho, MD, Chief Medical Editor
Some aspects of the trial may warrant closer scrutiny before clinicians begin to change practice patterns.
By Bryan Bechtel, Editor-in-Chief
BUSINESS OF RETINA
An Interview with Michael X. Repka, MD
By Aron Shapiro
By S. K. Steven Houston III, MD
A review of two common questions regarding coding for unique situations.
By Riva Lee Asbell
By Audina Berrocal, MD, and Michael Trese, MD
The decision should be based on the patient’s disease condition.
By Chi-Chun Lai, MD
By Quan Dong Nguyen, MD, MSc
By Sugandha Singh, BA; Murat Hasanreisoglu, MD; Renelle Pointdujour Lim, MD; and Carol L. Shields, MD
Injury from laser pointer trauma is a public health problem on the rise.
By Gregory D. Lee, MD, and David R. Lally, MD
SPECIAL FOCUS: FELLOWSHIP TRAINING
The differing structures of fellowship programs create a field of doctors with diverse experience.
By Jessica Randolph, MD; Joshua Mali, MD; and Ashleigh Levison, MD
Mentorship, which keeps retina alive, occurs in places other than the OR.
By Denis Jusufbegovic, MD, and Ahmet Ozkok, MD
A wealth of evidence supports anti-VEGF therapy in DME.
By Dilsher S. Dhoot, MD, and Dante Pieramici, MD
The outlook for new therapies for diabetic macular edema is bright—and it will have to be to meet the rising demand for treatment.
By Peter K. Kaiser, MD
Sustained-release platforms offer an alternative solution for patients with inadequate or no response to anti-VEGF therapy while addressing important compliance issues.
By Nancy Holekamp, MD
Subthreshold laser may provide a viable adjunct to pharmacologic therapy in selected patients.
By Sam E. Mansour, MSc, MD, FRCS(C), FACS
Third-party interpretations of fundus photographs could lighten the burden on retina specialists.
By Christopher J. Brady, MD
Three physicians offer their thoughts on when and why they consider changing therapy modalities.
By David Eichenbaum, MD; John W. Kitchens, MD; and Andrew A. Moshfeghi, MD, MBA
Routine, rapid visualization of the retinal periphery will facilitate earlier diagnosis, more accurate evaluation, and better treatment outcomes.
By Paul E. Tornambe, MD, FACS
Shlomit Schaal, MD, PhD, is an Associate Professor, Director of the Retina Service, and Director of the Vitreoretinal Fellowship Program at the University of Louisville School of Medicine, Kentucky.